CAMS Study

Quick Links to Current Research

The CAMS Trial is now complete. On trial completion, these pages have remained unchanged to allow people to see the development of the trial over time more clearly.

Cannabinoids in Multiple Sclerosis Trial

Progress - Active Centres

667 patients have been recruited out of a target number of 660.

Recruitment to the trial is now complete. The table below shows which centres are involved and how many patients they have each recruited. For full details about individual centres please see the List of Centres.

Centre Name (alphabetical by town) No. Patients
Ayrshire Central Hospital 25
Barnsley Community Rehab & Respite Unit 7
Belfast, Royal Victoria Hospital 21
Birmingham, Queen Elizabeth Hospital 16
Bristol, Frenchay Hospital 23
Cambridge, Addenbrookes Hospital 18
Cardiff, University Hospital of Wales / Rookwood 19
Coventry and Warwickshire Hospital 6
Dundee, Ninewells Hospital and Medical School 18
Hertford County Hospital 19
Ipswich Hospital 26
Leeds, St James' University Hospital 20
Leicester Royal Infirmary 21
Lincoln, Community Rehabilitation Centre 22
Liverpool, Walton Centre 15
London, Atkinson Morley's Hospital 13
London, Charing Cross Hospital 14
London, Guy's Hospital 8
London, Institute of Neurology, Queen Square 51
London, Queen Elizabeth Hospital Woolwich 13
Manchester, Hope Hospital 15
Newcastle, Royal Victoria Infirmary 21
Nottingham, University Hospital 30
Oxford, Radcliffe Infirmary 20
Plymouth, Derriford Hospital 99
Royal Preston Hospital 16
Stoke-on-Trent, North Staffordshire Royal Infirmary 20
Sheffield, Royal Hallamshire Hospital 10
Swansea, Morriston Hospital 6
Taunton and Somerset Hospital 21
Truro, Royal Cornwall Hospital 18
Wakefield, Pinderfields Hospital 16
Total 667/660